These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22794509)

  • 1. Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death.
    van der Heijden YF; Maruri F; Blackman A; Holt E; Warkentin JV; Shepherd BE; Sterling TR
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1162-7. PubMed ID: 22794509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality among tuberculosis patients in the Democratic Republic of Congo.
    Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community.
    Jeon CY; Calver AD; Victor TC; Warren RM; Shin SS; Murray MB
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):77-83. PubMed ID: 21276301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of smear-negative pulmonary tuberculosis in the United States, 1993-2008.
    Shah NS; Cavanaugh JS; Pratt R; Cain KP; Wells C; Laserson K; Nelson L
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1234-40. PubMed ID: 22748057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017.
    Edwards BD; Edwards J; Cooper R; Kunimoto D; Somayaji R; Fisher D
    PLoS One; 2020; 15(3):e0229691. PubMed ID: 32155169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions.
    Shen GH; Tsao TC; Kao SJ; Lee JJ; Chen YH; Hsieh WC; Hsu GJ; Hsu YT; Huang CT; Lau YJ; Tsao SM; Hsueh PR
    Int J Antimicrob Agents; 2012 Mar; 39(3):201-5. PubMed ID: 22285045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients.
    Lee JY; Lee HJ; Kim YK; Yu S; Jung J; Chong YP; Lee SO; Choi SH; Shim TS; Kim YS; Woo JH; Kim SH
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4005-12. PubMed ID: 27090178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe.
    Macpherson P; Dimairo M; Bandason T; Zezai A; Munyati SS; Butterworth AE; Mungofa S; Rusakaniko S; Fielding K; Mason PR; Corbett EL
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1390-6. PubMed ID: 22283900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
    Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia.
    Tseng YT; Chuang YC; Shu CC; Hung CC; Hsu CF; Wang JY
    Crit Care; 2012 Oct; 16(5):R207. PubMed ID: 23098258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.
    Kamolwat P; Nateniyom S; Chaiprasert A; Disratthakit A; Mahasirimongkol S; Yamada N; Smithtikarn S
    Trop Med Int Health; 2021 Jan; 26(1):45-53. PubMed ID: 32997863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
    Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
    BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda.
    Luzze H; Johnson DF; Dickman K; Mayanja-Kizza H; Okwera A; Eisenach K; Cave MD; Whalen CC; Johnson JL; Boom WH; Joloba M;
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):361-7. PubMed ID: 23407224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of tuberculosis in first 6 months after initiation of antiretroviral therapy: a case-control study.
    Peck RN; Luhanga A; Kalluvya S; Todd J; Lugoba S; Fitzgerald DW; Downs JA
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1047-51. PubMed ID: 22691942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
    BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mortality in adults hospitalized for active tuberculosis in a low HIV prevalence setting.
    Lui G; Wong RY; Li F; Lee MK; Lai RW; Li TC; Kam JK; Lee N
    PLoS One; 2014; 9(3):e92077. PubMed ID: 24642794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.